EUVIMEDEUVIMED entdecken
Open Access

Primary care physicians and laypersons’ perceptions of multicancer detection clinical trial designs

Goli Samimi iD, Sarah M Temkin iD, Carol J Weil iD, Paul K Han iD, Elyse LeeVan, Wendy S Rubinstein iD, Tessa Swigart iD, Sarah Caban iD, Katherine Dent, Lori M Minasian iD

JNCI Cancer Spectrum · 2024

DOI: 10.1093/jncics/pkae084 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JNCI Cancer Spectrum, 2024. Verfasst von Goli Samimi und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cancer Prevention, National Cancer Institute, Bethesda, MD, USA. Hauptthemen laut MEDLINE: Physicians, Primary Care, Focus Groups, Clinical Trials as Topic, Research Design. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, National Cancer Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The National Cancer Institute Cancer Screening Research Network is launching a pilot study (Vanguard) to determine feasibility of successful completion of a clinical trial of multicancer detection tests. This focus group study reports perceptions of primary care physicians and laypersons of different clinical trial designs and willingness to participate in a multicancer detection clinical trial.

Methods

We undertook 14 focus groups with 88 laypersons and 6 focus groups with 45 primary care physicians. Participants were shown graphics of clinical trial designs and asked for their reactions. Focus group recordings were transcribed verbatim, and thematic analysis of the transcripts were conducted to identify emergent themes.

Results

Primary care physician and layperson participants recognized the importance of conducting clinical trials to determine the clinical utility of multicancer detection tests. Primary care physicians expressed reluctance to participate in trials because of workload burden, and laypersons expressed hesitancy about enrolling in the control group. Primary care physicians and laypersons expressed concern about a study design in which multicancer detection test results would not be returned to the control group (intended effect), but they respectively indicated a willingness to refer patients to, or participate in, a multicancer detection test clinical trial given transparent and clear communication on collection and use of biospecimens and data, particularly if a multicancer detection test would eventually be run and results eventually returned.

Conclusion

This study yielded important insights to guide trial design in planning prospective evaluation of multicancer detection testing. Maintaining transparency and trust while possibly withholding multicancer detection test results to maximize trial feasibility and efficiency is of particular concern.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Physicians, Primary CareFocus GroupsClinical Trials as TopicResearch DesignHumansFemaleMaleMiddle AgedAdultPilot ProjectsEarly Detection of CancerAttitude of Health PersonnelAgedNeoplasmsFeasibility StudiesPerceptionPatient Selection

Autor:innen und Institutionen

  • Division of Cancer Prevention, National Cancer Institute, Bethesda, MD, USA.
  • Office of Research on Women's Health, National Institutes of Health, Bethesda, MD, USA.
  • Human Research Protections and Bioethics, Independent Consultant, Bethesda, MD, USA.
  • Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, MD, USA.
  • ICF Next, Fairfax, VA, USA.

ORCID-Profile: Goli Samimi, Sarah M Temkin, Carol J Weil, Paul K Han, Wendy S Rubinstein, Tessa Swigart, Sarah Caban, Lori M Minasian

Förderung

  • NCI NIH HHS
  • National Cancer Institute

Zitieren

APA

Samimi, G., Temkin, S. M., Weil, C. J., Han, P. K., LeeVan, E., Rubinstein, W. S., Swigart, T., Caban, S., Dent, K., & Minasian, L. M. (2024). Primary care physicians and laypersons’ perceptions of multicancer detection clinical trial designs. JNCI Cancer Spectrum. https://doi.org/10.1093/jncics/pkae084

Vancouver

Samimi G, Temkin SM, Weil CJ, Han PK, LeeVan E, Rubinstein WS, et al. Primary care physicians and laypersons’ perceptions of multicancer detection clinical trial designs. JNCI Cancer Spectrum. 2024. doi:10.1093/jncics/pkae084

BibTeX
@article{Samimi2024,
  author = {Samimi, Goli and Temkin, Sarah M and Weil, Carol J and Han, Paul K and LeeVan, Elyse and Rubinstein, Wendy S and Swigart, Tessa and Caban, Sarah and Dent, Katherine and Minasian, Lori M},
  title = {Primary care physicians and laypersons’ perceptions of multicancer detection clinical trial designs},
  journal = {JNCI Cancer Spectrum},
  year = {2024},
  doi = {10.1093/jncics/pkae084}
}
Kostenlos starten →